The Protective Function of the Pineal Gland in Tardive Dyskinesia

References

• Aldegunde M., Miquez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neurosciences 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Anton-Tay F., Chou C., Anton S., Wurtman R. J. Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–278
   PubMed Web of Science ®Google Scholar
• Anton-Tay F., Diaz J. L., Fernandez-Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
   Web of Science ®Google Scholar
• Bedard P. J., Boucher R., Daigle M., DiPaolo T. Similar effect of estradiol and haloperidol on experimental dyskinesia in monkeys. Psychoneuroendocrinology 1984; 9: 375–379
   PubMed Web of Science ®Google Scholar
• Bhargava H. N. Effects of prolyl-Leucyl-Glycinamide and cyclo (Leucyl-glycine) on the super-sensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats. Neuropharmacology 1984; 23: 439–444
   PubMed Web of Science ®Google Scholar
• Brown R., Kocsis J. H., Caroff S. Differences in nocturnal melatonic secretion between melancolic depressed patients and control subjects. American Journal of Psychiatry 1985; 142: 811–816
   PubMed Web of Science ®Google Scholar
• Chiu S., Paulose C. S., Mishra R. K. Effect of L-propyl-L-Leucyl-glycinamide (PLG) on neuroleptic-drug induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide. Science 1981; 214: 1261–1262
   PubMed Web of Science ®Google Scholar
• Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movements induced by L-dopa in mice. Science 1971; 173: 450–452
   PubMed Web of Science ®Google Scholar
• Dubocovich M. L. Melatonin as a potent modulator of dopamine release in the retina. Nature 1983; 306: 782–784
   PubMed Web of Science ®Google Scholar
• Ehrensing R. H., Kastin A. J., Larsons P. F., Bishop G. A. Melanocyte stimulating hormone release inhibiting factor-I and tardive dyskinesia. Diseases of the Nervous System 1977; 38: 303–307
   PubMedGoogle Scholar
• Erlich S. S., Apuzzo M. L. J. The pineal gland: anatomy, physiology, and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Ferrier I. N., Arendt J., Johnstone E. C. Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight. Clinical Endocrinology 1982; 17: 181–187
   PubMed Web of Science ®Google Scholar
• Fibiger H. C., Lloyd K. G. Neurological substrates of tardive dyskinesia: the GABA hypothesis. Trends in Neurosciences 1984; 1: 462–464
   Google Scholar
• Hamra B. J., Nasrallah H. A., Clancy J., Finn R. Psychiatric diagnosis and risk for tardive dyskinesia. Archives of General Psychiatry 1983; 40: 346–347
   PubMed Web of Science ®Google Scholar
• Hartley R., Parwick D., Smith J. A. The inhibition of pineal hydroxyindole-O-methyltransferase by haloperidol and fluphenazine. Journal of Pharmacy and Pharmacology 1972; 24: 100–103, (suppl)
   Web of Science ®Google Scholar
• Klawans H. L. The pharmacology of tardive dyskinesia. American Journal of Psychiatry 1977; 130: 82–86
   Google Scholar
• Kopp N., Clausrat B., Tappaz M. Evidence for the presence of melatonin in the human brain. Neuroscience Letters 1980; 19: 237–242
   PubMed Web of Science ®Google Scholar
• Korsgaard S. Baclofen in the treatment of neuroleptic induced tardive dyskinesia. Acta Psychiatrica Scandinavica 1976; 54: 17–54
   PubMed Web of Science ®Google Scholar
• Kozell L., Sandyk R., Wagner G. C., Fischer H. The effects of L-tryptophan on haloperidol induced movement disorder in the rat. Life Sciences 1987; 41: 1739–1744
   PubMed Web of Science ®Google Scholar
• Naylor R. J., Olley J. E. The distribution of haloperidol in rat brain. British Journal of Pharmacology 1969; 36: 208P–209P
   Web of Science ®Google Scholar
• Sandyk R. Estrogens and the pathophysiology of Parkinson's disease. International Journal of Neuroscience, (in press)
   Google Scholar
• Sandyk R. Neuroleptic-opioid interaction: relevance to tardive dyskinesia. International Journal of Neuroscience 1986; 30: 33–36
   PubMed Web of Science ®Google Scholar
• Sandyk R., Consroe P., Iacono R. P. L-tryptophan in drug-induced movement disorder with insomnia. New England Journal of Medicine 1987; 314: 1257
   Web of Science ®Google Scholar
• Sandyk R., Bamford C. R., Fisher H. Efficacy of L-tryptophan in neuroleptic-induced tardive dyskinesia. Neurology 1988; 38: 128, (suppl)
   Google Scholar
• Sandyk R., Fisher H. Enhancement of neuroleptic-induced movement disorder in the rat by pinealectomy. 1988, (submitted)
   Google Scholar
• Sandyk R., Fisher H. Serotonin in movement disorders. International Journal of Neuroscience, (in press)
   Web of Science ®Google Scholar
• Sandyk R., Fisher H. Treatment with p-chloroamphetamine enhances the development of neuroleptic-induced orofacial dyskinesias in the rat. International Journal of Neuroscience, (in press)
   Web of Science ®Google Scholar
• Sugden D., Morris R. D. Changes in regional brain levels of tryptophan, 5-hydroxytryptamine, 5-hydroxyindoleacetic acid, dopamine and noradrenaline after pinealectomy. Journal of Neurochemistry 1979; 32: 1593–1594
   PubMed Web of Science ®Google Scholar
• Tamminga C., Crayton J., Chase T. Improvement in tardive dyskinesia after muscimol therapy. Archives of General Psychiatry 1979; 36: 595–598
   PubMed Web of Science ®Google Scholar
• Tarsy D., Baldessarini R. J. The pathophysiologic bases of tardive dyskinesia. Biological Psychiatry 1977; 12: 431–450
   PubMed Web of Science ®Google Scholar
• Van Heuven-Nolsen D., Ronald De Kloet E., Versteeg D. H. G. Pro-Leu-GlyNH2 affects dopamine and noradrenaline utilisation in rat limbic-forebrain nuclei. Brain Research 1984; 322: 213–218
   PubMed Web of Science ®Google Scholar
• Waldhauser F., Steger H. Changes in melatonin secretion with age and pubescence. Journal of Neural Transmission 1986; 21: 183–197, (suppl)
   Google Scholar
• Zisapel N., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus. Brain Research 1983; 212: 378–381
   Google Scholar